Future concepts for neoadjuvant and adjuvant treatment of (resectable) pancreatic cancer

Chirurg. 2022 Apr 4. doi: 10.1007/s00104-022-01623-w. Online ahead of print.ABSTRACTPancreatic cancer still has a very unfavorable prognosis. This is true even for the comparably small group of patients (maximum 15%) who are diagnosed with a clearly resectable tumor. The article provides information on the current statements of the S3 guidelines on adjuvant and neoadjuvant treatment of resectable pancreatic cancer and describes adjuvant and neoadjuvant treatment strategies. Furthermore, the article pursues the questions of if and for whom a total neoadjuvant treatment is suitable and which options of a personalized treatment are available for resectable pancreatic cancer.PMID:35376964 | DOI:10.1007/s00104-022-01623-w
Source: Der Chirurg - Category: Surgery Authors: Source Type: research